Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Scientific Reports|August 24, 2021
The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALSAmy Keerie, Heledd Brown-Wright, Isaac Kirkland, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 21, 2020
Glucagon-like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping reviewMark P Maskery, Christian Holscher, Stephanie P Jones, et al.
Sheng Li Xue Bao : [Acta Physiologica Sinica]|June 29, 2016
[Neuroprotective effects of a novel antidiabetic drug (D-Ser2)Oxm on amyloid β protein-induced cytotoxicity]Yu-Fei Han, Christian Holscher, Zhao-Jun Wang, et al.
Brain : a Journal of Neurology|January 10, 2016
Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathologyAdrian Olmos-Alonso, Sjoerd T T Schetters, Sarmi Sri, et al.
Hormones and Behavior|November 26, 2019
A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic miceZhao-Jun Wang, Yu-Fei Han, Fang Zhao, et al.
Journal of Alzheimer'S Disease : JAD|July 16, 2014
Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodiesStewart F Graham, Muhammad Bin Nasaruddin, Manus Carey, et al.
Journal of Alzheimer'S Disease : JAD|November 2, 2014
Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodiesStewart F Graham, Muhammad Bin Nasarauddin, Manus Carey, et al.
Pageof 3